The Addex platform has enabled the discovery of multiple proprietary candidates with novel pharmacological properties with the potential to treat several unmet medical disorders of the central nervous system (CNS). Addex compounds are allosteric modulators, all identified using our proprietary biological tools from to screen our corporate library of small molecules, and all acting on the allosteric site of targets of interest. Addex over the last 15 years has industrialised the identification and optimization of such compounds, resulting in several of our programs delivering compounds to be tested in man.